ASX down, staples and banks hit hard
The ASX has slipped (again) as the trade war chaos unfolds. WiseTech is scrambling to fill director spots and Virgin has a new CEO.
Stockhead
Clarity reports ‘excellent’ prostate cancer trail results
Clarity Pharmaceuticals will move to the next stage of its phase II trial to test its isotope-based therapy on prostate cancer patients.
KNG dispatches Leliyn graphite concentrate
A pivotal step has been taken at the Leliyn graphite project in the Northern Territory with the shipment of a bulk sample of concentrate to Germany.
HPA is the high-tech commodity to watch
High purity alumina is seeing increased demand in a range of high-end technological uses. Here are the companies that are positioned to capitalise on this growth.
More Stories
Renerve joins ASX today
When Renerve makes its IPO on the ASX today, it will join Orthocell (ASX:OCC) as one of only two nerve-repair companies to be listed on the local bourse.
Orthocell appoints Singapore distributor
Orthocell appoints Device Technologies Asia as exclusive distributor of nerve-repair product Remplir in Singapore.
GCM tapping niche but lucrative market
Successful research into the production of topaz single-crystal mullite fibre could allow Green Critical Minerals to tap into niche metals market.
Aroa product revenue jumps 27pc
Soft-tissue repair company Aroa Biosurgery’s product revenue is up 27% to NZ$39.1 million in H1 FY25 with Myriad sales driving growth.
IPO market could see 2025 revival
Lion Selection Group’s Hedley Widdup is optimistic a strong gold market could bring cash back into junior resources next year.
Anglo seals coal deal
The US$3.8bn sale of Anglo American’s Queensland coal operations to Peabody shows the value miners still place on the Asian market.
Post IPO, Vitrafy is ready to freeze out its rivals
Cryopreserver Vitrafy Life Sciences face stiff competition, but believes it has the ingredients for success under CEO and former MasterChef winner Brent Owens.
Ovanti appoints firm for US BNPL expansion
Fintech Ovanti has appointed a New York firm as it looks to launch its BNPL offering in the US and eyes a listing on a US exchange.
Altech secures offtake intent from green hydrogen JV
RefLau, a joint venture between utility firms Enertrag SE and Energiequelle GmbH, will buy 30 MWh of Altech Batteries’ Cerenergy energy storage capacity in the first year.
Trump’s tariffs rattle markets
The ASX dropped as Trump’s tariff threat rattled markets, but at least the day saw some gainers, including BlueScope, Reece and EML Payments.
Original URL: https://www.dailytelegraph.com.au/business/stockhead/page/199